Play all audios:
Access through your institution Buy or subscribe Over a 10-year period, amyloid A (AA) amyloidosis was the predominant cause of progressive renal disease in patients with current or prior
intravenous drug use and chronic kidney disease who underwent renal biopsy in Frankfurt, Germany, being responsible for 50% of cases. 67% of the patients with AA amyloidosis were HIV
positive compared with 17% of the patients without AA amyloidosis (_P_ = 0.036). The researchers suggest that the increased frequency and duration of infections and the immunosuppression in
intravenous drug users with HIV might promote the development of AA amyloidosis. This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your
institution Subscribe to this journal Receive 12 print issues and online access $209.00 per year only $17.42 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access
to full article PDF Buy now Prices may be subject to local taxes which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read
our FAQs * Contact customer support ORIGINAL RESEARCH PAPER * Jung, O. _ et al_. Renal AA-amyloidosis in intravenous drug users—a role for HIV-infection? _BMC Nephrol._
doi:10.1186/1471-2369-13-151 Download references RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE HIV and renal AA amyloidosis in intravenous drug users.
_Nat Rev Nephrol_ 9, 64 (2013). https://doi.org/10.1038/nrneph.2012.270 Download citation * Published: 11 December 2012 * Issue Date: February 2013 * DOI:
https://doi.org/10.1038/nrneph.2012.270 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative